Bone marrow necrosis (BMN) is a relatively uncommon clinicopathologic entity. The
etiology is diverse, and malignancy, especially hematopoietic in origin, is the most common …

Materials and Methods In this study, 206 adult patients with HM who were receiving
chemotherapy (88 females, 42.7%; 118 males, 57.3%) were studied between June 1997 and …

Sweet's syndrome (SS) developed in two patients with acute myeloid leukaemia (AML)
treated with granulocyte colony stimulating factor (G‐CSF) for febrile neutropenia due to AML …

Palmar–plantar erythrodysesthesia (PPE) is a distinctive and relatively frequent toxic reaction
related to some chemotherapeutic agents. Doxorubicin, cytarabine, docetaxel, fluorouracil, …

Angiogenesis has a major role in the pathogenesis of malignancies. Studies involving the
role of angiogenesis have been most commonly performed in solid tumors. However, studies …

Background Trastuzumab is a recombinant humanized monoclonal antibody used to treat
human epidermal growth factor receptor 2 positive breast cancer, with recognized associated …

Purpose Awareness of advances in the nutritional aspects of cancer care and translation of
this information into clinical practice are important for oncology practitioners to effectively …

Aim: Gastrointestinal stromal tumor is the most common mesenchymal neoplasia in the
gastrointestinal tract and has a broad spectrum of pathological patterns and also clinical features …

We evaluated efficacy and toxicity profiles of fludarabine, Ara-C, idarubicin, and G-CSF (Ida-FLAG)
combination chemotherapy in 56 refractory and/or relapsed acute leukemia patients. …

Rituximab (the chimeric anti-CD20 antibody) is widely used in the treatment of CD20 positive
non-Hodgkin’s lymphoma (NHL). The response rate at relapse after repeated use in prior …